Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000)

被引:23
作者
Goubin, A [1 ]
Auclerc, MF
Auvrignon, A
Patte, C
Bergeron, C
Hémon, D
Clavel, J
机构
[1] INSERM, U754, Villejuif, France
[2] Univ Paris Sud, IFR69, Villejuif, France
[3] French Natl Registry Childhood Leukaemia & Lympho, Villejuif, France
[4] Hop St Louis, FRALLE Grp, Paris, France
[5] Hop Trousseau, LAME Grp, Paris, France
[6] LMB, Inst Gustave Roussy, Villejuif, France
[7] LMT, Ctr Leon Berard, Lyon, France
关键词
children; survival; acute leukaemia; lymphoma; population-based cancer registry; France;
D O I
10.1016/j.ejca.2005.08.041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This article describes the survival after childhood acute leukaemia (AL) and non-Hodgkin's lymphoma (NHL) of French population aged less than 15 years. The French National Registry of Childhood Leukaemia and Lymphoma recorded 3995 cases of acute lymphoblastic leukaemia (ALL), 812 of acute myeloid leukaemia (AML) and 1137 of NHL over the period from 1990 to 2000. Overall survival rates at 5 years were 82% (95% CI 80-83), 58% (95% CI 54-61) and 87% (95% CI 85-89) for ALL, AML and NHL, respectively. Survival after AL increased from 77% (95% Cl 75-80) in 1990-1992 to 85% (95% Cl 83-87) in 1997-2000 for ALL and from 47% (95% CI 41-54) to 61% (95% CI 55-67) for AML. Among AL cases, children aged 1-4 years had the most favourable prognosis. Down's syndrome was associated with poor survival after ALL. No gender-related variations in survival were in evidence. The results reported herein are similar to those reported by other European registries and clinical trials. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:534 / 541
页数:8
相关论文
共 31 条
[1]  
AUVRIGNON A, 2003, PROTOCOLE MULTICENTR, V2
[2]  
Brugières L, 1998, BLOOD, V92, P3591
[3]   Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France:: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999 [J].
Clavel, J ;
Goubin, A ;
Auclerc, MF ;
Auvrignon, A ;
Waterkeyn, C ;
Patte, C ;
Baruchel, A ;
Leverger, G ;
Nelken, B ;
Philippe, I ;
Sommelet, D ;
Vilmer, E ;
Bellec, S ;
Perillat-Menegaux, F ;
Hémon, D .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2004, 13 (02) :97-103
[4]   Variation in survival of European children with acute lymphoblastic leukaemia, diagnosed in 1978-1992: the EUROCARE study [J].
Coebergh, JW ;
Pastore, G ;
Gatta, G ;
Corazziari, I ;
Kamps, W .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (06) :687-694
[5]   Improved outcome of acute myeloid leukaemia in Down's syndrome [J].
Craze, JL ;
Harrison, G ;
Wheatley, K ;
Hann, IM ;
Chessells, JM .
ARCHIVES OF DISEASE IN CHILDHOOD, 1999, 81 (01) :32-37
[6]   Definition of a standard-risk group in children with AML [J].
Creutzig, U ;
Zimmerman, M ;
Ritter, J ;
Henze, G ;
Graf, N ;
Löffler, H ;
Schellong, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 104 (03) :630-639
[7]   Cancer incidence among children in France, 1990-1999 [J].
Desandes, E ;
Clavel, J ;
Berger, C ;
Bernard, JL ;
Blouin, P ;
de Lumley, L ;
Demeocq, F ;
Freycon, F ;
Gembara, P ;
Goubin, A ;
Le Gall, E ;
Pillon, P ;
Sommelet, D ;
Tron, I ;
Lacour, B .
PEDIATRIC BLOOD & CANCER, 2004, 43 (07) :749-757
[8]   Critical study of prognostic factors in childhood acute lymphoblastic leukaemia: differences in outcome are poorly explained by the most significant prognostic variables [J].
Donadieu, J ;
Auclerc, MF ;
Baruchel, A ;
Leblanc, T ;
Landman-Parker, J ;
Perel, Y ;
Michel, G ;
Cornu, G ;
Bordigoni, P ;
Sommelet, D ;
Leverger, G ;
Hill, C ;
Schaison, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (03) :729-739
[9]   Acute myeloid leukemia and gDown syndrome evolution of modern therapy - State of the art review [J].
Gamis, AS .
PEDIATRIC BLOOD & CANCER, 2005, 44 (01) :13-20
[10]   Survival from acute non-lymphocytic leukaemia (ANLL) and chronic myeloid leukaemia (CML) in European children since 1978: a population-based study [J].
Gatta, G ;
Luksch, R ;
Coleman, MP ;
Corazziari, I .
EUROPEAN JOURNAL OF CANCER, 2001, 37 (06) :695-702